BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 29853346)

  • 1. The loss of BAP1 protein expression predicts poor prognosis in patients with nonmetastatic clear cell renal cell carcinoma with inferior vena cava tumor thrombosis.
    Oka S; Inoshita N; Miura Y; Oki R; Miyama Y; Nagamoto S; Ogawa K; Sakaguchi K; Kondoh C; Kurosawa K; Urakami S; Takano T; Okaneya T
    Urol Oncol; 2018 Aug; 36(8):365.e9-365.e14. PubMed ID: 29853346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of BAP1 expression in metastatic tumor tissue is an event of poor prognosis in patients with metastatic clear cell renal cell carcinoma.
    da Costa WH; Fares AF; Bezerra SM; Morini MA; de Toledo Benigno LA; Clavijo DA; Fornazieri L; Rocha MM; da Cunha IW; de Cassio Zequi S
    Urol Oncol; 2019 Jan; 37(1):78-85. PubMed ID: 30446457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgical treatment of renal cell carcinoma: Can morphological features of inferior vena cava tumor thrombus on computed tomography or magnetic resonance imaging be a prognostic factor?
    Choi DK; Jeon HG; Jeong CW; Kwak C; Song C; Chung J; Hong SK; Hong SH; Seo SI;
    Int J Urol; 2017 Feb; 24(2):102-109. PubMed ID: 28111837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type II papillary histology predicts poor outcome in patients with renal cell carcinoma and vena cava thrombus.
    Kim KH; You D; Jeong IG; Kwon TW; Cho YM; Hong JH; Ahn H; Kim CS
    BJU Int; 2012 Dec; 110(11 Pt B):E673-8. PubMed ID: 22973869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BAP1 immunohistochemistry predicts outcomes in a multi-institutional cohort with clear cell renal cell carcinoma.
    Kapur P; Christie A; Raman JD; Then MT; Nuhn P; Buchner A; Bastian P; Seitz C; Shariat SF; Bensalah K; Rioux-Leclercq N; Xie XJ; Lotan Y; Margulis V; Brugarolas J
    J Urol; 2014 Mar; 191(3):603-10. PubMed ID: 24076305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcome of surgical management for patients with renal cell carcinoma involving the inferior vena cava.
    Terakawa T; Miyake H; Takenaka A; Hara I; Fujisawa M
    Int J Urol; 2007 Sep; 14(9):781-4. PubMed ID: 17760741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of BAP1 protein expression in the first metastatic site predicts prognosis in patients with clear cell renal cell carcinoma.
    Miura Y; Inoshita N; Ikeda M; Miyama Y; Oki R; Oka S; Kondoh C; Ozaki Y; Tanabe Y; Kurosawa K; Urakami S; Kohno T; Okaneya T; Takano T
    Urol Oncol; 2017 Jun; 35(6):386-391. PubMed ID: 28284891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative systemic inflammation response index indicates poor prognosis in patients treated with resection of renal cell carcinoma with inferior vena cava tumor thrombus.
    Lv Z; Feng HY; Wang T; Ma X; Zhang X
    Urol Oncol; 2022 Apr; 40(4):167.e9-167.e19. PubMed ID: 35042663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transabdominal two-cavity approach for radical nephrectomy combined with inferior vena cava thrombectomy for malignant thrombus caused by renal cell carcinoma: a case series.
    Novotny R; Chlupac J; Marada T; Borovicka V; Vik V; Voska L; Janousek L; Fronek J
    J Med Case Rep; 2018 Oct; 12(1):313. PubMed ID: 30355283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prognostic value of venous tumor thrombus in renal cell carcinoma].
    García-Fadrique G; Budía-Alba A; Ruiz-Cerdá JL; Morales-Solchaga G; Pontones JL; Jiménez-Cruz JF
    Actas Urol Esp; 2012 Jan; 36(1):29-34. PubMed ID: 21802784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of BAP1 protein expression is an independent marker of poor prognosis in patients with low-risk clear cell renal cell carcinoma.
    Joseph RW; Kapur P; Serie DJ; Eckel-Passow JE; Parasramka M; Ho T; Cheville JC; Frenkel E; Rakheja D; Brugarolas J; Parker A
    Cancer; 2014 Apr; 120(7):1059-67. PubMed ID: 24382589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic impact of concomitant loss of PBRM1 and BAP1 protein expression in early stages of clear cell renal cell carcinoma.
    da Costa WH; da Cunha IW; Fares AF; Bezerra SM; Shultz L; Clavijo DA; da Silva DV; Netto GJ; Guimaraes GC; Cassio Zequi S
    Urol Oncol; 2018 May; 36(5):243.e1-243.e8. PubMed ID: 29426696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal cell carcinoma with inferior vena cava involvement: Prognostic effect of tumor thrombus consistency on cancer specific survival.
    Mager R; Daneshmand S; Evans CP; Palou J; Martínez-Salamanca JI; Master VA; McKiernan JM; Libertino JA; Haferkamp A; ; Haferkamp A; Capitanio U; Carballido JA; Chantada V; Chromecki T; Ciancio G; Daneshmand S; Evans CP; Gontero P; González J; Hohenfellner M; Huang WC; Koppie TM; Libertino JA; Espinós EL; Lorentz A; Martínez-Salamanca JI; Master VA; McKiernan JM; Montorsi F; Novara G; O'Malley P; Pahernik S; Palou J; Moreno JL; Pruthi RS; Faba OR; Russo P; Scherr DS; Shariat SF; Spahn M; Terrone C; Tilki D; Vázquez-Martul D; Donoso CV; Vergho D; Wallen EM; Zigeuner R
    J Surg Oncol; 2016 Nov; 114(6):764-768. PubMed ID: 27562252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of nuclear BAP1 protein expression is a marker of poor prognosis in patients with clear cell renal cell carcinoma.
    Minardi D; Lucarini G; Milanese G; Di Primio R; Montironi R; Muzzonigro G
    Urol Oncol; 2016 Aug; 34(8):338.e11-8. PubMed ID: 27085487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of surgery on the prognosis of metastatic renal cell carcinoma with IVC thrombus received TKI therapy.
    Kwon T; Lee JL; You D; Jeong IG; Song C; Ahn H; Kim CS; Hong JH
    J Surg Oncol; 2014 Aug; 110(2):145-50. PubMed ID: 24706355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical strategy for treating renal cell carcinoma with thrombus extending into the inferior vena cava.
    Jibiki M; Iwai T; Inoue Y; Sugano N; Kihara K; Hyochi N; Sunamori M
    J Vasc Surg; 2004 Apr; 39(4):829-35. PubMed ID: 15071451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic role of BAP1 in pT1 clear cell carcinoma in partial nephrectomy specimens.
    Minardi D; Lucarini G; Milanese G; Montironi R; Di Primio R
    Virchows Arch; 2017 Jul; 471(1):99-105. PubMed ID: 28488170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of renal vein and inferior vena cava involvement in renal cell carcinoma.
    Wagner B; Patard JJ; Méjean A; Bensalah K; Verhoest G; Zigeuner R; Ficarra V; Tostain J; Mulders P; Chautard D; Descotes JL; de la Taille A; Salomon L; Prayer-Galetti T; Cindolo L; Valéri A; Meyer N; Jacqmin D; Lang H
    Eur Urol; 2009 Feb; 55(2):452-9. PubMed ID: 18692951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Outcome of Resection of Inferior Vena Cava Superior to the Renal Vein in Renal Cell Carcinoma with Vena Caval Tumor Thrombus].
    Kashima S; Narita S; Saito M; Takahashi M; Maita S; Tsuruta H; Numakura K; Maeno A; Inoue T; Tsuchiya N; Satoh S; Yamamoto H; Yamamoto Y; Habuchi T
    Hinyokika Kiyo; 2016 Jun; 62(6):287-94. PubMed ID: 27452491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Robot-assisted Laparoscopic Inferior Vena Cava Thrombectomy: Different Sides Require Different Techniques.
    Wang B; Li H; Ma X; Zhang X; Gu L; Li X; Fan Y; Gao Y; Liu K; Zhu J
    Eur Urol; 2016 Jun; 69(6):1112-9. PubMed ID: 26706105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.